SCHEMBL4778875

SCHEMBL4778875

FC1CCN(c2cc[c]cn2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.37
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.33
ABL1 P00519 1/20 0.33
LMNA P02545 1/20 0.33
HTR3E A5X5Y0 1/20 0.33
MEN1 O00255 1/20 0.33
HTR3B O95264 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
HTR3A P46098 1/20 0.33
KMT2A Q03164 1/20 0.33
HTR3D Q70Z44 1/20 0.33
HTR3C Q8WXA8 1/20 0.33
CKS1B P61024 1/20 0.33
SKP1 P63208 1/20 0.33
SKP2 Q13309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17316636 0.89 CHRM3 (0.36) HRH3PDE10ACHRM3PDE4APDE4B
SCHEMBL17316302 0.85 CHRM3 (0.34) PDE10ACHRM3PDE4APDE4BPDE4C
SCHEMBL8194170 0.84 MAPT (0.48) MAPTKDM4ELMNAMEN1TSHR
SCHEMBL8199221 0.84 SMPD3 (0.39) MAPTKDM4ELMNAPDE10APDE4D
SCHEMBL2067822 0.82 MAPT (0.36) MAPTKDM4ELMNACYP1A2TSHR
SCHEMBL743397 0.82 MAPT (0.40) MAPTLMNACYP1A2TSHR
SCHEMBL8199180 0.82 ALDH1A1 (0.46) HRH3KDM4EPDE10AGPR119
SCHEMBL182759 0.81 ALDH1A1 (0.44) MAPTKDM4ELMNAMEN1CYP1A2
SCHEMBL1316269 0.81 MAPT (0.41) MAPTLMNACYP1A2TSHR
SCHEMBL4770306 0.80 HRH4 (0.44) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265256-A1 Phosphodiesterase 10 inhibitors AMGEN INC. 2007-11-15 US claimed
EP-1991530-A1 CINNOLINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS Amgen Inc. (US) 2008-11-19 EP disclosed
US-20070265256-A1 Phosphodiesterase 10 inhibitors AMGEN INC. 2007-11-15 US disclosed
WO-2007098169-A1 CINNOLINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. (US) 2007-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265256-A1 Phosphodiesterase 10 inhibitors PDE7A, PDE7B, PDE10A HRH3 4562/4885MAPT 3278/4885KDM4E 2328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.